PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
19026985-0	2009	Inhibition of human DNA polymerase beta activity by the anticancer prodrug Cloretazine.	laromustine	75-86	DNA polymerase beta	Homo sapiens	20-39	
19026985-2	2009	Cloretazine is reported here to inhibit the nucleotidyl-transferase activity of purified human DNA polymerase beta (Pol beta), a principal enzyme of DNA base excision repair (BER).	laromustine	0-11	DNA polymerase beta	Homo sapiens	95-114	
19026985-2	2009	Cloretazine is reported here to inhibit the nucleotidyl-transferase activity of purified human DNA polymerase beta (Pol beta), a principal enzyme of DNA base excision repair (BER).	laromustine	0-11	DNA polymerase beta	Homo sapiens	116-124	
19026985-5	2009	Inhibition of the polymerase activity of Pol beta may account for some of the synergism between Cloretazine"s two reactive subspecies in cytotoxicity assays.	laromustine	96-107	DNA polymerase beta	Homo sapiens	41-49	
19026985-7	2009	Furthermore, while therapeutically relevant concentrations of Cloretazine inhibited the polymerase activity of Pol beta, the enzyme"s lyase activity, which may also participate in BER, was not significantly inhibited.	laromustine	62-73	DNA polymerase beta	Homo sapiens	111-119